ConnectiveRx
ConnectiveRx is a US healthcare technology company providing technology-enabled hub services, patient affordability programs, point-of-care EHR messaging, and specialty pharmacy distribution for pharmaceutical manufacturers, healthcare providers, and patients across 84 million+ patient journeys annually.
- Company typePrivate
- Founded2015
- HeadquartersWhippany, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What ConnectiveRx does
ConnectiveRx (legal entity PSKW, LLC) is a privately held US healthcare technology company that delivers technology-enabled patient support, affordability, and adherence solutions for pharmaceutical manufacturers, healthcare providers, and patients on specialty and branded medications. Its platform bundles hub services (benefits verification, prior authorization, patient enrollment, case management), end-to-end patient affordability programs, point-of-care EHR messaging, and a proprietary Enterprise Data Platform (EDP) that aggregates patient-level data across hub, copay, and pharmacy services into a single patient-journey view. Recent product extensions include ConnectiveRx Pharmacy, a fully-licensed dispensing pharmacy launched in September 2025 for direct-to-patient specialty medication distribution, and ShieldRx, an AI-driven pharmacy monitoring and misuse-prevention engine co-developed with EagleForce and launched in April 2026. The company operates the largest clinically embedded prescriber network cited in its marketing, reaching 1.2 million prescribers across 750,000+ EHR systems and 84 million+ patients annually.
The business model is built on enterprise contracts with pharmaceutical manufacturers, primarily through subscription or recurring service fees for hub services and EHR messaging campaigns, transaction-based fees from pharmacy dispensing, and revenue-protection contracts for ShieldRx. Go-to-market runs through enterprise field sales and inside sales teams targeting pharma commercialization leads, an RFP submission process, and thought leadership at industry conferences (Asembia, Hub East, PAP, POC Now, HIMSS, MM+M Transform). Named and awarded customers include Biogen, AstraZeneca, and Teva. ConnectiveRx maintains dual headquarters in Whippany, NJ and Pittsburgh, PA, with operations support in Fairfield, and operates as a privately held company backed by Genstar Capital, Harvest Partners Structured Capital, and Blackstone Tactical Opportunities following a March 2020 funding round.
ConnectiveRx firmographics
Firmographics- Name
- ConnectiveRx
- Legal name
- PSKW, LLC
- Website
- https://connectiverx.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- ConnectiveRx is a US healthcare technology company providing technology-enabled hub services, patient affordability programs, point-of-care EHR messaging, and specialty pharmacy distribution for pharmaceutical manufacturers, healthcare providers, and patients across 84 million+ patient journeys annually.
- Ownership category
- akta.pro rank
ConnectiveRx industry classification
Industry- Product category
- Pharmaceutical Patient Access & Hub Services
- NAICS
- All Other Outpatient Care Centers (621498), Social Assistance (624)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Patient Access Programs & Affordability (Copay/Hubs/PSP) (HLAIAKAG)
- akta.pro secondary industries
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Medication Adherence, Reminders & Patient Support (HLACAKAF), Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN), PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools) (HLAEAKAL)
Keywords
Where ConnectiveRx is headquartered
LocationHeadquarters
- HQ city
- Whippany
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
ConnectiveRx business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Hub Services for Pharma Manufacturers: ConnectiveRx provides technology-enabled hub services to pharmaceutical manufacturers for specialty and branded medications, including benefits verification, prior authorization support, patient enrollment, and adherence programs. Revenue is derived from service fees charged to pharma manufacturer clients, typically under contractual arrangements tied to program scope and patient volume.
- Point-of-Care EHR Messaging: In-workflow EHR messaging services delivered to healthcare providers, generating revenue through brand programs sponsored by pharmaceutical manufacturer clients. Pricing is based on provider reach, message volume, and therapeutic area coverage.
- Pharmacy Dispensing Services: Direct-to-patient specialty medication distribution through ConnectiveRx Pharmacy, a fully-licensed dispensing pharmacy. Revenue generated from pharmaceutical manufacturers as part of integrated patient support and distribution solutions.
- ShieldRx (Pharmacy Monitoring): AI-driven pharmacy monitoring and misuse prevention solution targeting revenue protection for pharmaceutical manufacturers. Revenue is derived from service contracts with pharma brands, based on detection performance and claim volume monitored.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
ConnectiveRx product offering
Product offeringCore offering
ConnectiveRx delivers technology-enabled patient support and access solutions for pharmaceutical manufacturers, including hub services (benefits verification, prior authorization, patient enrollment, copay assistance, and adherence messaging), point-of-care EHR messaging campaigns reaching 1.2M+ prescribers, direct-to-patient specialty medication dispensing through ConnectiveRx Pharmacy, AI-driven pharmacy misuse monitoring (ShieldRx), and the Enterprise Data Platform unifying the patient journey across services. The company operates as a single-partner solution designed to help patients get on and stay on therapy while protecting manufacturer revenue.
Differentiator
Problem solved
Functional benefit
Brands
- ConnectiveRx Pharmacy: A tech-driven, fully-licensed dispensing pharmacy for direct-to-patient specialty medication distribution.
- ShieldRx
- EHR Network
- Enterprise Data Platform (EDP)
Products and services
- Hub Services and Patient Support End-to-end patient support services for pharmaceutical manufacturers including benefits verification, prior authorization support, patient enrollment, case management, copay assistance, and adherence messaging for patients prescribed specialty and branded medications.
- Point-of-Care EHR Messaging In-workflow messaging campaigns delivered to healthcare providers (physicians, nurse practitioners, physician assistants) directly within electronic health records, supporting prescription savings offers, clinical communications, formulary pull-through, and patient adherence reminders across cardiovascular, diabetes, women's health, and other therapeutic areas.
- ConnectiveRx Pharmacy Fully-licensed dispensing pharmacy providing integrated direct-to-patient specialty medication distribution for pharmaceutical manufacturers, managing intake, fulfillment, and the complete patient access process alongside ConnectiveRx's hub services.
- ShieldRx AI-driven pharmacy monitoring and misuse-prevention engine that evaluates pharmacy claims in real time using AI risk scoring and a pharmacist resolution center, protecting pharmaceutical manufacturer revenue from pharmacy fraud, misuse, and invalid copay behavior. Addresses an estimated $5B in annual manufacturer revenue loss.
- Enterprise Data Platform (EDP) Enterprise data warehouse and visual intelligence platform that unifies patient-level data from hub services, copay programs, and pharmacy claims into a single real-time view of the patient journey, enabling pharma brands and field reimbursement managers to access dashboards and predictive insights.
- Electronic Benefit Verification (eBV) and Electronic Prior Authorization (ePA) Electronic services that automate benefits verification and prior authorization, providing real-time coverage insights to healthcare providers and accelerating patient onboarding onto specialty and branded therapies.
- Non-Commercial Pharmacy A non-commercial pharmacy channel that expands patient enrollment opportunities by connecting patients at the pharmacy level, capturing those who might otherwise fall through traditional enrollment gaps in hub programs.
- ScriptGuide In-workflow EHR messaging program focused on persistence and adherence, designed to improve new-prescription fill rates and ongoing medication adherence across multiple therapeutic areas.
- Rx Savings Assistant® (EHR-integrated prescription savings) Prescription savings software facilitating prescription savings offers directly within electronic health records, integrated into ConnectiveRx's EHR Network to support healthcare providers and patients across the US.
Quantifiable outcome
- 13-15% higher first-fill rates and stronger patient adherence across key therapeutic areas (cardiovascular, diabetes, women's health)
- +5 more outcomes
Companies that use ConnectiveRx
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles1 record
ConnectiveRx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature8 records
ConnectiveRx partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- EagleForcecoreConnectiveRx and EagleForce jointly developed and launched ShieldRx, an AI-driven pharmacy monitoring and misuse prevention engine. EagleForce contributed real-time identity and transaction intelligence capabilities, while ConnectiveRx provided pharmacy workflow integration and adjudication expertise. The partnership combines AI-driven risk models with EagleForce's transaction intelligence to flag suspicious pharmacy activity before claims are paid, addressing $5 billion in annual manufacturer revenue loss.
- Medicom DigitalcoreConnectiveRx acquired Rx Savings Assistant® from Medicom Digital, integrating it into its EHR Network which connects healthcare providers and patients across the US. The software facilitates prescription savings offers directly within electronic health records.
- Amazon Web Services (AWS)coreConnectiveRx has de-carbonized its operations by partnering with AWS for all cloud computing solutions. AWS provides the cloud infrastructure supporting ConnectiveRx's SaaS platform for hub services, EHR integrations, pharmacy monitoring, and data analytics.
- Point of Care Marketing Association (POCMA)minorConnectiveRx joined POCMA as a member, with President and Chief Commercial Officer Frank Dana joining POCMA's board of directors. The partnership provides ConnectiveRx a platform to enhance education, thought-leadership, and solutions that advance the point-of-care industry and support patients along their health journey.
Scale indicators13 records
Recent moves7 records
Expansion highlights6 records
ConnectiveRx competitors and assessment
Company assessmentDirect peers
- TrialCard: Pharma-focused hub services and patient access solutions provider offering copay programs, affordability, adherence, and patient support services to branded and specialty manufacturers—directly overlapping with ConnectiveRx's hub and affordability offerings.
- OptimizeRx: Digital health company delivering in-workflow EHR messaging to HCPs for pharma manufacturers, including financial assistance, clinical messaging, and adherence support—directly comparable to ConnectiveRx's Point-of-Care EHR Network.
- AssistRx: Specialty therapy patient access and hub services provider offering eBV, ePA, patient enrollment, and adherence for pharma manufacturers—closely overlapping with ConnectiveRx's hub services platform.
- CoverMyMeds (McKesson): McKesson-owned ePA, benefit verification, and patient access platform serving providers, pharmacists, and pharma manufacturers—directly competing in ePA/eBV and integrated hub workflows that ConnectiveRx also delivers.
- PatientPoint: Point-of-care health information network reaching providers and patients in-office and via digital channels, including EHR-integrated messaging for pharma brands—closely comparable to ConnectiveRx's point-of-care messaging offering.
- Outcome Health: Point-of-care health education and messaging platform delivering content and brand programs through HCP office networks and digital channels—competing with ConnectiveRx for pharma point-of-care messaging budgets.
- UBC (United BioSource): Pharma services provider offering patient access, hub, adherence, and affordability programs for manufacturers as part of Express Scripts' broader services portfolio—directly overlapping with ConnectiveRx's hub and patient support offerings.
Broad incumbents
- IQVIA: Global CRO and commercial solutions provider with patient access, hub, and real-world evidence capabilities serving pharma manufacturers—offers overlapping capabilities to ConnectiveRx as part of a much broader services portfolio.
- McKesson: Diversified pharmaceutical distributor and healthcare services giant owning CoverMyMeds, US Oncology, and specialty pharmacy capabilities—competes with ConnectiveRx across hub, specialty pharmacy, and ePA, but as part of a much broader enterprise.
Others
- Surescripts: Health information network operating e-prescribing, benefit, and clinical interoperability infrastructure used by EHRs, pharmacies, and PBMs—an enabling/adjacent platform whose e-prescribing and real-time benefit tools are complementary and partially competitive with ConnectiveRx's eBV/ePA workflows.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
ConnectiveRx social profiles
Digital presenceConnectiveRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
ConnectiveRx leadership team
Management profileNumber of profiles
Profiles21 records
ConnectiveRx funding detail
Funding detailFunding overview
Funding rounds1 record
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ConnectiveRx M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ConnectiveRx
What does ConnectiveRx do?
ConnectiveRx delivers technology-enabled patient support and access solutions for pharmaceutical manufacturers, including hub services (benefits verification, prior authorization, patient enrollment, copay assistance, and adherence messaging), point-of-care EHR messaging campaigns reaching 1.2M+ prescribers, direct-to-patient specialty medication dispensing through ConnectiveRx Pharmacy, AI-driven pharmacy misuse monitoring (ShieldRx), and the Enterprise Data Platform unifying the patient journey across services. The company operates as a single-partner solution designed to help patients get on and stay on therapy while protecting manufacturer revenue.
Is ConnectiveRx a public or private company?
ConnectiveRx is a private company. It is classified as private equity controlled and is currently operating.
When was ConnectiveRx founded?
ConnectiveRx was founded in 2015. It employs 1,001 to 5,000 people.
Where is ConnectiveRx based?
ConnectiveRx is headquartered in Whippany, United States, in the North America region.
How does ConnectiveRx make money?
Four revenue lines are on record. Hub Services for Pharma Manufacturers are the primary driver. The others are point-of-Care EHR Messaging, pharmacy Dispensing Services and shieldRx (Pharmacy Monitoring).
Who are ConnectiveRx's main competitors?
Direct peers on record are TrialCard, OptimizeRx, AssistRx, CoverMyMeds (McKesson), PatientPoint, Outcome Health and UBC (United BioSource). Broad incumbents are IQVIA and McKesson. Surescripts is listed as an others.
Does ConnectiveRx have an API?
No public API is recorded for ConnectiveRx.
What industry is ConnectiveRx in?
ConnectiveRx's product category is Pharmaceutical Patient Access & Hub Services. Its primary akta.pro industry code is HLAIAKAG, Patient Access Programs & Affordability (Copay/Hubs/PSP), with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 621498 and its SIC code is 8000.